author-photo

Feng Hsiu Su

Merck & Co.

2

Papers

35

Citations

Citation Trend

Filter By

Papers (1) Sort By

Journal Conference Others

Safety and efficacy of a fixed-dose combination regimen of grazoprevir, ruzasvir, and uprifosbuvir with or without ribavirin in participants with and without cirrhosis with chronic hepatitis C virus genotype 1, 2, or 3 infection (C-CREST-1 and C-CREST-2, part B): two randomised, phase 2, open-label trials

2017 The Lancet Gastroenterology & Hepatology
Show All
- Source
- Cite
- Save
Citations (13)